Merck
CN
Search Within
文件类型

108-74-7

应用筛选条件
关键词:'108-74-7'
显示 1-30 共 114 条结果 关于 "108-74-7" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
102 111 101 93 97 108 101 98 92 89 95 91 100 JNK/SAPK1c SAPK2a/p38 99 94 93 111 95 75 100 85 2 0 86 98 138 93 108 102 84 88 104 SAPK2b/p38β2 97 107
The Effective Use of Protein Kinase Inhibitors
102 111 101 93 97 108 101 98 92 89 95 91 100 JNK/SAPK1c SAPK2a/p38 99 94 93 111 95 75 100 85 2 0 86 98 138 93 108 102 84 88 104 SAPK2b/p38β2 97 107
Data Sheet - A2228
Monoclonal Anti-beta-Actin, Clone AC-74 (A2228) - Data Sheet Monoclonal Anti-β-Actin, Clone AC-74 produced in mouse, purified immunoglobulin . Catalog Number A2228 Product Description
Product Information Sheet - A2522
form.5 Monomeric rabbit actin has been used to inhibit DNAse I, with a binding constant = 5 x 108 M-1.10 The atomic structure of the actin:DNase I complex along with the amino acid sequence has been
Data Sheet - B7150 - Lot 61K8804
40000 60000 80000 100000 120000 m/z Abundance 41 46 52 65 66 74 81 92 94 108 120 134 137 150 165
Data Sheet - B7150 - Lot 061K88041
80 90 100 110 120 130 140 150 160 0 5000 15000 m/z Abundance 41 52 65 74 81 92 108 120 137 150 165 10000
LABORATORY NOTEBOOK ISSUANCE PAGE
.0 85 30 .9 74 32 .0 6 35 .4 5 39 .9 48 69 .7 23 72 .6 3 74 .9 22 78 .9 6 79 .9 04 83 .7 98 11 4. 82 11 8. 71 12 1.
Lab Notebook Guidelines
.0 85 30 .9 74 32 .0 6 35 .4 5 39 .9 48 69 .7 23 72 .6 3 74 .9 22 78 .9 6 79 .9 04 83 .7 98 11 4. 82 11 8. 71 12 1.
LABORATORY NOTEBOOK ISSUANCE PAGE
.0 85 30 .9 74 32 .0 6 35 .4 5 39 .9 48 69 .7 23 72 .6 3 74 .9 22 78 .9 6 79 .9 04 83 .7 98 11 4. 82 11 8. 71 12 1.
LABORATORY NOTEBOOK ISSUANCE PAGE
.0 85 30 .9 74 32 .0 6 35 .4 5 39 .9 48 69 .7 23 72 .6 3 74 .9 22 78 .9 6 79 .9 04 83 .7 98 11 4. 82 11 8. 71 12 1.
TB029
1 2130 Sau96I 14 Sau3AI 24 ScaI 1 3619 ScrFI 14 SfaNI 19 SfcI 4 108 2511 2702 3380 SgrAI 1 181 SphI 1 337 SspI 1 3943 StyI 1 1140 TaqI 7 137 145 423 898 1039 2346 3790 TaqII 6 441 2148 3487 3672 3825
Data Sheet - G6160
titration assay. References 1. Pepperkok, R., et al., Cell, 74, 71 (1993). 2. Griffiths, G., et al., J. Cell Sci., 108, 2839 (1995). 3. Kreis, T., et al., Annu. Rev. Cell Dev.
Impurities & Related Compounds: Reference Materials
75-07-0 64-19-7 67-64-1 67-64-1 75-05-8 75-05-8 100-66-3 123-86-4 108-90-7 108-90-7 67-66-3 98-82-8 110-82-7 110-82-7 60-29-7 108-20-3 108-20-3 67-68-5
DataSheet - P3752
10664-10670 (1981). 6. Tu, S.I. et al., Plant Physiol., 88(1), 61-68 (1988). 7. Zyła, K. et al., Br. J. Nutr., 74(1), 3-17 (1997). 8. López, R.S. et al., Acta Agriculturae Scandinavica, Section
Acrylamido Buffers
1629 - 16 43 224 19 208 260 651 -
DataSheet - P8340
20 g (wet weight) of bovine liver, or in 10 mL of cell lysate from CHO cells at a cell density of 108 cells per mL. CHO cells were grown on DMEM with 10% FCS (heat-inactivated). Note: Not
Product Information Sheet-collh-ro
available in US 10 735 086 001 500 g, Not available in US 10 735 094 001 1 kg, Not available in US 10 735 108 001 1 2 3 1 2 3 https://www.sigmaaldrich.com
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
precursor 55 1 60 1 IPI00021857 Apolipoprotein C-III precursor 179 2 108 2 172 2 231 2 100 2 IPI00306959 Keratin, type I cytoskeletal 7 63 1 IPI00022488 Hemopexin precursor 97 2 109 3 70 1
Data Sheet - G2279
Borelli, E., Science, 263, 95 (1994). 18. Pepperkok, R., et al., Cell, 74, 71 (1993). 19. Griffiths, G., et al., J. Cell Sci., 108, 2839 (1995). 20. Kreis, T. E., et al., Annu. Rev. Cell Dev. Biol., 11
Product Information Sheet - P2545
51(1), 3-22 (1982). 6. Ey, P.L. et al., Immunochem., 15(7), 429-436 (1978). 7. Surolia, A. et al., Trends Biochem. Sci., 7(2), 74-76 (1982). 8. Ishikawa, E., and Kato, K., Scand. J. Immunol
Data Sheet - H107
109) 80 Ro 20-1724, PDE inhibitor (R-111) 500 Ro 41-0960, COMT inhibitor (R-108) 1.4 Ryanodine (R-100) 9.3 SKF-83566 HCl (S-110) 14 >1400 Spiperone
XP725 Antibody Number-Lot Number 071M4826
g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53
Product Information Sheet - C0926
109 80 Ro 20-1724, PDE inhibitor B 8279 500 Ro 41-0960, COMT inhibitor R 108 1.4 Ryanodine R 100 9.3 SKF-83566 HCl S 110 14 >1400 Spiperone HCl
PKH Dye Reference Guide
51, 66, 74, 93, 94, 99, 111, 129, 131, 136, 137, 139, 145, 148, 155 Other blood and/or bone marrow cells (erythrocytes, neutrophils, platelets, stromal cells) 37-39, 52, 68, 95, 108, 115
Product Information Sheet - T1426
Towards predicting enzymatic protein hydrolysis". Wageningen University, Ph.D. dissertation, pp. 42, 74, 108 (2018). 22. Xie, Bailu, "Molecular mechanisms of YAP signalling in the context of cancer". University
Verfication summary-03-0202-00
HMN108012 3 MRD (1:2) 57.71 7.9 14% 115.42 7.9 7% - 3 1:4 29.56 1.5 5% 118.24 1.5 1% 102% 3 1:8 15.55 1.0 6% 124.38 1.0 1% 108% 3 1:16 8.14 0.6 7% 130.23 0.6 0% 113%
Verfication summary-03-0202-00
HMN108012 3 MRD (1:2) 57.71 7.9 14% 115.42 7.9 7% - 3 1:4 29.56 1.5 5% 118.24 1.5 1% 102% 3 1:8 15.55 1.0 6% 124.38 1.0 1% 108% 3 1:16 8.14 0.6 7% 130.23 0.6 0% 113%
Mouse iPS Cell Boost Supplement
If the number of cells in the well at the time of transduction is 1 x 105, the viral titer is 3 x 108 IFU/mL, and a desired MOI is 20, then the volume of virus required is:
Protocol: Rat Vascular Injury Magnetic Bead Panel 1
Matrix % Recovery in Serum Matrix CAV-1 105 100 CTGF 108 101 IL-6 105 103 MCP-1 108 104 TNFα 97 93 GRO/KC/CINC-1 108 104 TIMP-1 105 105 tPAI-1 100 102 VEGF 107
1/4